A detailed history of Wendell David Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Wendell David Associates Inc holds 11,547 shares of AMGN stock, worth $3.05 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
11,547
Previous 11,423 1.09%
Holding current value
$3.05 Million
Previous $3.57 Million 4.26%
% of portfolio
0.36%
Previous 0.36%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$309.38 - $337.38 $38,363 - $41,835
124 Added 1.09%
11,547 $3.72 Million
Q2 2024

Jul 22, 2024

SELL
$262.75 - $319.31 $6,568 - $7,982
-25 Reduced 0.22%
11,423 $3.57 Million
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $6,184 - $7,464
23 Added 0.2%
11,448 $3.26 Million
Q4 2023

Jan 22, 2024

BUY
$255.7 - $288.46 $7,671 - $8,653
30 Added 0.26%
11,425 $3.29 Million
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $4,285 - $5,067
-20 Reduced 0.18%
11,395 $2.53 Million
Q3 2022

Oct 18, 2022

SELL
$224.46 - $253.15 $25,812 - $29,112
-115 Reduced 1.0%
11,415 $2.57 Million
Q2 2022

Jul 14, 2022

SELL
$230.71 - $256.74 $92,284 - $102,696
-400 Reduced 3.35%
11,530 $2.81 Million
Q4 2021

Jan 24, 2022

BUY
$198.88 - $227.6 $125,493 - $143,615
631 Added 5.58%
11,930 $2.68 Million
Q2 2021

Jul 19, 2021

SELL
$233.58 - $259.14 $4,204 - $4,664
-18 Reduced 0.16%
11,299 $2.75 Million
Q1 2021

Apr 20, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.01%
11,317 $2.82 Million
Q4 2020

Jan 22, 2021

SELL
$216.38 - $257.67 $37,000 - $44,061
-171 Reduced 1.49%
11,316 $2.6 Million
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $13,850 - $18,369
-76 Reduced 0.66%
11,487 $2.33 Million
Q1 2019

Apr 11, 2019

BUY
$180.87 - $203.88 $6,149 - $6,931
34 Added 0.29%
11,563 $2.2 Million
Q4 2018

Jan 17, 2019

SELL
$178.4 - $208.25 $77,604 - $90,588
-435 Reduced 3.64%
11,529 $2.24 Million
Q1 2018

Apr 11, 2018

SELL
$169.43 - $198.0 $16,773 - $19,602
-99 Reduced 0.82%
11,964 $2.04 Million
Q4 2017

Jan 16, 2018

SELL
$168.79 - $188.59 $40,003 - $44,695
-237 Reduced 1.93%
12,063 $2.1 Million
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $2.06 Million - $2.35 Million
12,300
12,300 $2.29 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.